Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study

RATIONALE & OBJECTIVE: Heart failure (HF) is an important cause of morbidity and mortality among individuals with chronic kidney disease (CKD). A large body of evidence from preclinical and clinical studies implicates excess levels of fibroblast growth factor 23 (FGF23) in HF pathogenesis in CKD...

Descripción completa

Detalles Bibliográficos
Autores principales: Leidner, Alexander S., Cai, Xuan, Zelnick, Leila R., Lee, Jungwha, Bansal, Nisha, Pasch, Andreas, Kansal, Mayank, Chen, Jing, Anderson, Amanda Hyre, Sondheimer, James H., Lash, James P., Townsend, Raymond R., Go, Alan S., Feldman, Harold I., Shah, Sanjiv J., Wolf, Myles, Isakova, Tamara, Mehta, Rupal C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616385/
https://www.ncbi.nlm.nih.gov/pubmed/37915961
http://dx.doi.org/10.1016/j.xkme.2023.100723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616385/
https://www.ncbi.nlm.nih.gov/pubmed/37915961
http://dx.doi.org/10.1016/j.xkme.2023.100723

Ejemplares similares